1. Home
  2. MDGL vs FSS Comparison

MDGL vs FSS Comparison

Compare MDGL & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • FSS
  • Stock Information
  • Founded
  • MDGL 2011
  • FSS 1901
  • Country
  • MDGL United States
  • FSS United States
  • Employees
  • MDGL N/A
  • FSS N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • FSS Auto Manufacturing
  • Sector
  • MDGL Health Care
  • FSS Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • FSS Nasdaq
  • Market Cap
  • MDGL 7.1B
  • FSS 6.1B
  • IPO Year
  • MDGL N/A
  • FSS N/A
  • Fundamental
  • Price
  • MDGL $336.23
  • FSS $93.65
  • Analyst Decision
  • MDGL Buy
  • FSS Buy
  • Analyst Count
  • MDGL 14
  • FSS 3
  • Target Price
  • MDGL $351.67
  • FSS $100.00
  • AVG Volume (30 Days)
  • MDGL 357.1K
  • FSS 343.8K
  • Earning Date
  • MDGL 02-26-2025
  • FSS 02-26-2025
  • Dividend Yield
  • MDGL N/A
  • FSS 0.51%
  • EPS Growth
  • MDGL N/A
  • FSS 44.95
  • EPS
  • MDGL N/A
  • FSS 3.45
  • Revenue
  • MDGL $76,813,000.00
  • FSS $1,837,900,000.00
  • Revenue This Year
  • MDGL N/A
  • FSS $9.71
  • Revenue Next Year
  • MDGL $195.95
  • FSS $7.09
  • P/E Ratio
  • MDGL N/A
  • FSS $27.17
  • Revenue Growth
  • MDGL N/A
  • FSS 10.33
  • 52 Week Low
  • MDGL $189.00
  • FSS $76.85
  • 52 Week High
  • MDGL $368.29
  • FSS $102.18
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 52.41
  • FSS 39.60
  • Support Level
  • MDGL $334.13
  • FSS $95.88
  • Resistance Level
  • MDGL $354.49
  • FSS $100.36
  • Average True Range (ATR)
  • MDGL 13.20
  • FSS 2.45
  • MACD
  • MDGL 0.16
  • FSS -0.39
  • Stochastic Oscillator
  • MDGL 43.12
  • FSS 0.22

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: